Self-administered rehabilitation for motion sickness and vestibular disorders
StableEyes With Active Neurophysiological Feedback
This study tests a self-guided rehab tool to see if it can help people with motion sickness and balance issues feel better by practicing head movements.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 48 (estimated) |
| Ages | 21 Years to 70 Years |
| Sex | All |
| Sponsor | Johns Hopkins University Academic / other |
| Locations | 2 sites (Baltimore, Maryland and 1 other locations) |
| Trial ID | NCT05622344 on ClinicalTrials.gov |
What this trial studies
This study evaluates a self-administered rehabilitation tool designed to help individuals with vestibular disorders, including vestibular schwannoma and motion sickness. Participants will perform guided head rotations in a structured manner, adjusting the amplitude based on their perception of motion sickness. The device tracks eye and head movements to assess the effectiveness of the rehabilitation. The goal is to enhance postural recovery and reduce symptoms of motion sickness through incremental training.
Who should consider this trial
Good fit: Ideal candidates include individuals diagnosed with unilateral vestibular schwannoma or those experiencing vestibular disorders who are in good general health.
Not a fit: Patients currently using anti-nausea medication or those with significant orthopedic or visual impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve the quality of life for patients suffering from motion sickness and vestibular disorders.
How similar studies have performed: While similar approaches have been explored, this specific method of self-guided rehabilitation using neurofeedback is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Provision of signed and dated informed consent form 2. Stated willingness to comply with all study procedures and availability for the duration of the study 3. In good general health as evidenced by medical history or diagnosed with unilateral vestibular schwannoma 4. Willing to adhere to the SWAN and/or vestibular rehabilitation regimen Exclusion Criteria: 1. Current use of anti-nausea medication 2. Presence of cervical spine pathology that limits head motion to \< 30 degrees in the horizontal or vertical plane (i.e. degenerative disc disease, rheumatoid arthritis) 3. Any orthopedic pathology that prevents walking or standing independently (i.e. recent surgery) 4. Legal blindness (20/200 or worse visual acuity) 5. Treatment using a motion sickness investigational drug or other motion sickness behavioral intervention within 30 days
Where this trial is running
Baltimore, Maryland and 1 other locations
- Johns Hopkins University — Baltimore, Maryland, United States (Recruiting)
- Naval Medical Research Unit — Dayton, Ohio, United States (Enrolling_by_invitation)
Study contacts
- Principal investigator: Matthew Stewart, MD PhD — Johns Hopkins University
- Study coordinator: Michael Schubert, PhD
- Email: mschube1@jhmi.edu
- Phone: 4108427403
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.